A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...
1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
